Pyrrolizidine alkaloid monocrotaline causes lung injury by damaging pulmonary endothelium. This damage alters endothelial functions like angiotensin converting enzyme (ACE) activity and prostacyclin (PGI2) production, preceding structural lung abnormalities.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: